Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival
Year: 2016
Type: article
Study design: Observational Study
Source: Leukemia
DOI: 10.1038/leu.2016.140
Institutions: Mayo Clinic, Essentia Health
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2408593795